705 patents currently held
83 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
26
Ending by 2030
Nov 2026
Next term end
522
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2037 · High confidence
Also notable
Ends Jan 2034 · High confidence
Also notable
Ends no later than Mar 2035 · Medium confidence
Methods, Devices, and Manufacture of the Devices for Musculoskeletal Reconstructive Surgery
US 11,628,001
Cited by 167 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2037.
System and Method for Efficient Use of Network Bandwidth Based on User Profiles and Other Data
US 10,178,580
Cited by 64 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2034.
Prebiotic Formulations
US 10,624,934
Cited by 34 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2035. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 11 fees due Nov 21 to 30, 2026 · next Nov 21
- 12 fees due Dec 2 to 27, 2026 · next Dec 2
- 5 fees due Jan 9 to 30, 2027 · next Jan 9
- 13 fees due Feb 6 to 28, 2027 · next Feb 6
- 9 fees due Mar 10 to 29, 2027 · next Mar 10
- 21 fees due Apr 3 to 30, 2027 · next Apr 3
- 13 fees due May 3 to 28, 2027 · next May 3
- 21 fees due Jun 10 to 29, 2027 · next Jun 10
- 11 fees due Jul 2 to 30, 2027 · next Jul 2
- 7 fees due Aug 4 to 23, 2027 · next Aug 4
- 11 fees due Sep 1 to 30, 2027 · next Sep 1
- 16 fees due Oct 7 to 30, 2027 · next Oct 7
- 7 fees due Nov 7 to 14, 2027 · next Nov 7
Recent changes
- Nov 9Assignment recorded on US 12,788,361: Liu, Jun and 1 other to Ohio State Innovation Foundation Recorded Nov 9, 2026, executed Oct 9, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76685, frame 239.
- Nov 6Assignment recorded on 1 record: Zhu, Hua and 1 other to Ohio State Innovation Foundation Recorded Nov 6, 2026, executed Sep 1, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76659, frame 125.
- 34 of the patents on this record were granted since Aug 19, 2026
- 1 term has ended since Aug 19, 2026
What they patent
The 5 largest of its 522 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Enhanced Flyback Converter | 19 in force | to Nov 2039 |
| Contact Lens Comprising Lenticular-Like Curve | 6 in force | to Nov 2037 |
| Data Delivery Using Acoustic Transmissions | 5 in force | to Jul 2038 |
| System and Method for Efficient Use of Network Bandwidth Based on User Profiles and Other Data | 5 in force | to Jan 2034 |
| Interpentrating Microstructures for Nanochannel-Based Cargo Delivery | 4 in force | to Jun 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,691,396 | Chimeric Peptides Comprising HER-2 B-Cell Epitopes and Measles Virus Fusion Protein T-Cell Epitopes In force · High confidence | In force | High confidence | |
| US 8,541,460 | PDK-1/AKT Signaling Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 7,767,191 | Combustion Looping Using Composite Oxygen Carriers In force · High confidence | In force | High confidence | |
| US 10,143,658 | Multistage Delivery of Active Agents In force · High confidence | In force | High confidence | |
| US 7,745,132 | Prognostic Indicators of Canine Lymphoid Neoplasia Using Tumor-Derived Plasma DNA In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 7,893,616 | Process to Determine Enzyme Activity In force · High confidence | In force | High confidence | |
| US 8,057,653 | Carbon Dioxide Sensor In force · High confidence | In force | High confidence | |
| US 7,694,547 | Robust High Temperature Composite and Co Sensor Made from Such Composite In force · High confidence | In force | High confidence | |
| US 8,741,944 | Anti-Infective Agents Against Intracellular Pathogens In force · High confidence | In force | High confidence | |
| US 10,030,273 | Microrna Expression in Human Peripheral Blood Microvesicles and Uses Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 705: 83 patents in force now held by others · 83 patents ended · 606 applications pending · 263 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.